Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
acetylcholine receptor
acetylcholine receptor antibody
acute disseminated encephalomyelitis
acute necrotizing encephalitis
acyclovir
advances in neurology
adverse drug reaction
algorithm
altered states of consciousness
alternative medicine
amyotrophic lateral sclerosis
anticonvulsants
antispasticity drugs
antiviral agents
asymptomatic
attention span
audiologic test to localize site of pathology
audiology
auditory evoked brainstem potentials
auditory evoked potentials
autoimmune disease
azathioprine
baclofen
Barkhof MR criteria for MS
behavior modification
behavioral disorder
black box warning
bladder dysfunction
blood dyscrasias, neurologic findings with
botulinum toxin
brain biopsy
brain scan
breast feeding
calcification, intracranial
caloric testing
cancer, cerebrovascular accident complicating patients with
cannabinoids
carcinoma
carcinoma of lung
cardiotoxicity
cataracts, congenital
central nervous system, infection of
cerebellar infarction
cerebral edema
cerebral edema, cytotoxic
cerebral infarction
cerebral infarction, hemorrhagic
cerebral palsy
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, cytology
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, xanthochromia of
cerebrovascular accident
cerebrovascular accident, mass effect with
cerebrovascular accident, rehabilitation of
cerebrovascular accident, thrombolytic agents in treatment
children
chills
chorioretinitis
cladribine
coma
comorbidities
complementary medicine
compliance
complications
concentration, impaired
concussion
congestive heart failure
controversies in neurology
conversion reaction
cop 1
cost
cost effectiveness
craniectomy, decompressive
critical care unit
cyst, porencephalic
cytomegalic inclusion disease
cytosine arabinoside
dementia
demyelinating disease
depression
depression, psychotic
dermatomyositis
diabetes mellitus
diagnostic criteria
differential diagnosis
diplopia
disability rating scale, neurological
disability, neurological
dizziness
drug induced neurologic disorders
dural arteriovenous malformation
dural sinus thrombosis
dyskinesia
efficacy
electroencephalogram
electron microscopy
electronystagmography
electronystagmography, abnormal
emotional lability
encephalitis
encephalitis, brainstem
encephalitis, clinical picture and treatment of
encephalitis, diagnosis of
encephalitis, viral
encephalitis, viral-causes of
epidemiology of neurology
episodic disorders
evidence-based research
evoked potentials
extinction on double simultaneous stimulation
eye movement, disorders of
facial nerve palsy
facial weakness
fatigue
fetus
fever
fibrinolytic agents
fibrinolytic agents, complications
fibromyalgia
fingolimod
flu-like illness
gadolinium
gag reflex, depressed
gait disorder
gammaglobulin therapy, intravenous
glioblastoma multiforme(astrocytoma Gr.III)
Guillain Barre syndrome
head injury
headache
hearing loss
herniation syndromes, intracranial
herpes labialis
herpes simplex encephalitis
herpes simplex encephalitis, differential diagnosis of
herpes simplex encephalitis, recurrent
herpes simplex encephalitis, treatment of
herpes simplex myelitis
herpes simplex virus
herpes simplex virus infection, immunosuppressed patient
herpes simplex virus, human nervous system and
herpes simplex virus, localization of
herpes simplex virus, malignancy with
herpes simplex virus, pathogenesis of
herpes simplex virus, pathology of
herpes simplex, neurocutaneous lesions in
herpes virus
herpes zoster
herpes, genital
HLA
hormone replacement
hospice
human herpesvirus 6
hydrocephalus
hypochondriasis
hypoglycorrhachia
iatrogenic neurologic disorders
imbalance
imbalance, postural
immunization, neurologic complications with
immunofluorescent exam of CSF cells
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
inclusion bodies, intranuclear
inclusion body myositis
infection
infection, latent
infectious mononucleosis
influenza immunization
interferon
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon inducer
internet
intracerebral hemorrhage
intracranial pressure, increased
intrathecal antispasticity drugs
intrauterine
intrauterine infection, viral
intrauterine infection, viral of CNS
iododeoxyuridine
JC virus
leg spasms
leg spasms, painful
leukemia
leukopenia
level of consciousness, decreased
limbic encephalitis
limbic system
lipoprotein receptor-related protein 4
liver function enzymes
lymphopenia
malformation, CNS, congenital
marihuana
McDonald criteria for MS
medical-legal aspects of neurology
meningitis
meningitis, aseptic
mental status, abnormal
methotrexate
microcephaly
micropthalmia
middle cerebral artery territory infarction
middle cerebral artery territory infarction, malignant
misdiagnosis
mitoxantrone
monoamines
monoamines, brain
monoclonal antibodies
mortality
motor dysfunction
motor neuron disease
movement disorder
movement disorder, psychogenic
MRI
MRI, abnormal
MRI, ADC maps
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion tensor
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, incidental finding
MRI, indications for
MRI, lesion burden
MRI, protocol
MRI, serial
MRI, spine
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, asymptomatic
multiple sclerosis, chronic progressive
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, plaque
multiple sclerosis, prognosis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, telling patient diagnosis of
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle pain
muscle weakness
muscular dystrophy
MuSK antibodies
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, diagnosis
myasthenia gravis, ocular
myasthenia gravis, receptor site in
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, variants
myasthenic crisis
myasthenic syndrome
myasthenic syndrome, treatment of
myelitis
myelitis, transverse
myocarditis
myofascial pain syndrome
myopathy
nabiximols
natalizumab
neglect
neoplasm, primary intracerebral
neurologic complications of, systemic cancer
neurologic consultation
neurologic disease
neurologic disease, diagnoses of
neurologic disease, incurable
neurologic evaluation
neurologist
neurolysis
neuromuscular junction
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuropathy
neuropathy, multifocal
neuropathy, peripheral, treatment
neutralizing antibodies
nystagmus
nystagmus, positional
ocular dysmetria
ophthalmoplegia
opportunistic infection, CNS
optic atrophy
optic neuritis
optic neuritis, treatment of
optokinetic nystagmus(O.K.N.)
optokinetic nystagmus, abnormal
oral contraceptives
oral contraceptives, neurologic complications with
outcome research
oxybutynin
pain, central
palliative care
Parkinson disease
pathologic reflex
patient information and support
Persistent postural-perceptual dizziness
personality change
physician as patient
plasmapheresis
pleocytosis of cerebrospinal fluid
pneumonia
polyinosinic cytidic acid(poly IC)
polyneuropathy, chronic inflammatory demyelinating
practice guidelines
precipitating factors
pregnancy, neurologic complications in
pressure sores
prethrombotic state
prevention of neurologic disorders
primary intracranial hypotension
prognosis
progressive multifocal leucoencephalopathy
pseudotumor
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
ptosis
ptosis, bilateral
pursuit eye movements
quality of life
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
review article
risk factors
risk-benefit assessment
rituximab
rubella virus
saccadic eye movements
safety
screening
seizure
seizure, psychomotor-temporal lobe
seizure, treatment of
selective serotonin reuptake inhibitors
serologic testing
serotonin norepinephrine reuptake inhibitors
serum glutamic oxaloacetic transaminase
sexual dysfunction in neurologic disease
sinusitis
somatosensory evoked potentials
spasticity
spasticity, treatment of
spatial neglect
spinal cord
spinal cord, injury of
spinal cord, injury, complications with
spinal cord, injury, functional capacity of patient with
spinal cord, injury, prognosis in
spinal cord, injury, sexual dysfunction in
stem cell tourism
stem cell transplantation
steroid
steroid therapy, CNS treatment and complications with
stiff man syndrome
subacute myelo-opticoneuropathy(S.M.O.N.)complex
suboccipital decompression
subspecialist
subtemporal decompression
systemic illness
talk
teleconsulting
telemedicine
teleneurology
telestroke
tender points
thoracic outlet syndromes
thymectomy
thymic hyperplasia
thymoma
thyroiditis
tinnitus
tinnitus, causes of
tissue plasminogen activator, intravenous
transplacental virus infections
trauma
treatment of neurologic disorder
trigeminal neuralgia
urinary tract infection
vaccination, neurologic complications with
vaccine
viral infection
viral infection, CNS
visual evoked response
walking
weakness
weakness, fatiguable
weakness, generalized
workers' compensation
workup
Showing articles 800 to 850 of 5079 << Previous Next >>

Outcome of and Prognostic Factors for Herpes Simplex Encephalitis in Adult Patients: Results of a Multicenter Study
Clin Inf Dis 35:254-260, Raschillas, F.,et al, 2002

The Differential Diagnosis of Multiple Sclerosis
JNNP 71(suppl II):ii9-ii15, Scolding, N., 2001

Isolated Demyelinating Syndromes: Comparison of CSF Oligoclonal Bands and Different MR Imaging Criteria to Predict Conversion to CDMS
Mult Scler 7:359-363, Tintore,M.,et al, 2001

Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis
JAMA 286:3083-3088,3127, Ascherio,A.,et al, 2001

The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001

The Prevalence of Sjogren Syndrome in Patients with Primary Progressive Multiple Sclerosis
Neurol 57:1359-1363,1357, de Seze,J.,et al, 2001

Oligoclonal Band Number as a Marker for Prognosis in Multiple Sclerosis
Arch Neurol 58:2044-2045, Avasarala,J.R.,et al, 2001

Phenylketonuria Presenting in Adulthood as Progressive Spastic Paraparesis With Dementia
JNNP 71:795-797, Kasim,S.,et al, 2001

Surgical Therapy for Tremor in Multiple Sclerosis
Neurol 57:1876-1882, Matsumoto,J.,et al, 2001

Problems With Diagnositc Criteria for Multiple Sclerosis
Lancet 358:1746-1747, Poser,C.M. &Brinar,V.V., 2001

Handicap After Acute Whiplash Injury
Neurol 56:1637-1643, Kasch,H.,et al, 2001

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001

Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001

Acute Motor Radiculopathy as a First Symptom of MS: Anatomic-radiologic Correlation
Neurol 56:1603-1604, Lavallee,P.,et al, 2001

A Longitudinal MRI Study of Histopathologically Defined Hypointense Multiple Sclerosis Lesions
Ann Neurol 49:793-796, Bitsch,A.,et al, 2001

Return to Driving After Head Injury
JNNP 70:761-766, Hawley,C.A., 2001

Autologous Hematopoietic Stem Cell Transplantation Suppresses Gd-enhanced MRI activity in MS
Neurol 57:62-68, Mancardi,G.L.,et al, 2001

A Three-item Scale for the Early Prediction of Stroke Recovery
Lancet 357:2095-2099, Baird,A.E.,et al, 2001

PRISMS-4: Long-Term Efficacy of Interferon-B-1a in Relapsing MS
Neurol 56:1628-1636,1620, The PRISMS Study Group, 2001

Measurement of Antibodies to Interferon Beta in Patients With Multiple Sclerosis
Arch Neurol 58:1299-1300,1301, Pachner,A.R., 2001

The Significance of Neutralizing Antibodies in Patients With Multiple Sclerosis Treated With Interferon Beta
Arch Neurol 58:1297-1298,1301, Rice,G., 2001

Narcolepsy Associated with Other Central Nervous System Disorders
Neurol 57:539-541, Malik,S.,et al, 2001

14-3-3 Protein in the CSF as Prognostic Marker in Early Multiple Sclerosis
Neurol 57:722-724, Martinez-Yelamos,A.,et al, 2001

MRI Characteristics of the MLF in MS Patients with Chronic Internuclear Ophthalmoparesis
Neurol 57:762-768, Frohman,E.M.,et al, 2001

Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001

Linear Pontine Trigeminal Root Lesions in Multiple Sclerosis
Arch Neurol 58:101-104, Nakashima,I.,et al, 2001

Multiple Sclerosis and Magnetic Resonance Imaging
Arch Neurol 58:35-36, Racke,M.K.,et al, 2001

Cerebellar Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies
Arch Neurol 58:225-230, Honorat,J.,et al, 2001

APOE Genotype is a Major Predictor of Long-Term Progression of Disability in MS
Neurol 56:312-316, Chapman,J.,et al, 2001

Hepatitis B Vaccination and the Risk of Multiple Sclerosis
NEJM 344:327-332,372,381, Ascherio,A.,et al, 2001

Vaccinations and the Risk of Relapse in Multiple Sclerosis
NEJM 344:319-326,372, Confavreux,C.,et al, 2001

Assessing the Risk of Early Multiple Sclerosis in Patients with Clinically Isolated Syndromes: the Role of a Follow Up MRI
JNNP 70:390-393, Brex,P.A.,et al, 2001

La Crosse Encephalitis in Children
NEJM 344:801-807, McJunkin,J.E.,et al, 2001

European/Canadian Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Glatiramer Acetate on Magnetic Resonance Imaging-Measured Disease Activity and Burden in Patients wi
Ann Neurol 49:290-297, Comi,G.,et al, 2001

Seizures in Multiple Sclerosis
Epilepsia 42:72-79, Sokic,D.V.,et al, 2001

The Influence of Cognitive Impairment on Driving Performance in Multiple Sclerosis
Neurol 56:1089-1094, Schultheis,M.R.,et al, 2001

Presence of Chlamydia pneumoniae DNA in the Cerebral Spinal Fluid is a Common Phenomenon in a Variety of Neurological Diseases and Not Restricted to Multiple Sclerosis
Ann Neurol 49:585-589,556, Gieffers,J.,et al, 2001

Disability and Quality of Life in Charcot-Marie-Tooth Disease Type 1
JNNP 70:548-550, Pfeiffer,G.,et al, 2001

CSF Oligoclonal Bands in MS Include Antibodies Against Chlamydophila Antigens
Neurol 56:1168-1176,1126,1128,1130, Yao,S.,et al, 2001

Evolution of Cerebral Infarct Volume Assessed by Diffusion-Weighted Magnetic Resonance Imaging
Arch Neurol 58:613-617, Lansberg,M.,G.,et al, 2001

Comparisons of Patient Self-report, Neurologic Examination, and Functional Impairment in MS
Neurol 56:934-937, Hoogervorst,E.L.J.,et al, 2001

Diffusion-Weighted Imaging and National Institutes of Health Stroke Scale in the Acute Phase of Posterior-Circulation Stroke
Arch Neurol 58:621-628, Linfante,I.,et al, 2001

Clinical and Neuroradiologic Features of Acute Disseminated Encephalomyelitis in Children
Neurol 56:1308-1312,1257, Hynson,J.L.,et al, 2001

Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001

Clinical Presentation of Left Atrial Cardiac Myxoma
Medicine 80:159-172, Pinede,L.,et al, 2001

Acute Disseminated Encephalomyelitis
Neurol 56:1313-1318,1257, Schwarz,S.,et al, 2001

Fulminant Liver Failure During Interferon Beta Treatment of Multiple Sclerosis
Neurol 56:1416, Yoshida,E.M.,et al, 2001

Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging Detects Cortical and Juxtacortical Multiple Sclerosis Lesions
Arch Neurol 58:742-748, Bakshi,R.,et al, 2001

Differential Diagnosis of Posterior Fossa Multiple Sclerosis Lesions--Neuroradiological Aspects
Neurol Sci 22 Suppl 2:S79-83, Falini,A.,et al, 2001

Onset of Multiple Sclerosis Associated With Anti-TNF Therapy
Neurol 57:1885-1888, Sicotte,N.L. &Voskuhl,R.R., 2001



Showing articles 800 to 850 of 5079 << Previous Next >>